Cargando…
Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients
Hepatitis C Virus (HCV) infection treatment has dramatically changed with the advent of direct-acting antiviral agents (DAAs). However, the efficacy of DAAs can be attenuated by the presence of resistance-associated substitutions (RASs) before and after treatment. Indeed, RASs detected in DAA treatm...
Autores principales: | Aldunate, Fabián, Echeverría, Natalia, Chiodi, Daniela, López, Pablo, Sánchez-Cicerón, Adriana, Fajardo, Alvaro, Soñora, Martín, Cristina, Juan, Hernández, Nelia, Moreno, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112080/ https://www.ncbi.nlm.nih.gov/pubmed/30186532 http://dx.doi.org/10.1155/2018/2514901 |
Ejemplares similares
-
Response to: Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”
por: Aldunate, Fabián, et al.
Publicado: (2019) -
Comment on “Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients”
por: Eybpoosh, Sana, et al.
Publicado: (2018) -
Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report
por: Aldunate, Fabián, et al.
Publicado: (2021) -
IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients
por: Echeverría, Natalia, et al.
Publicado: (2018) -
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy
por: Bertoli, Ada, et al.
Publicado: (2018)